<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34172001</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Late-onset neuromuscular disorders in the differential diagnosis of sarcopenia.</ArticleTitle><Pagination><StartPage>241</StartPage><MedlinePgn>241</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">241</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-021-02264-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sarcopenia is the age-related loss of muscle mass and strength. Undiagnosed late-onset neuromuscular disorders need to be considered in the differential diagnosis of sarcopenia.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Based on emblematic case reports and current neuromuscular diagnostic guidelines for three common late-onset neuromuscular disorders, a differential diagnostic approach for geriatric patients presenting with a sarcopenic phenotype is given.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients over 65&#xa0;years of age with sarcopenia, amyotrophic lateral sclerosis, inclusion body myositis and myotonic dystrophy type 2 were recruited. All patients were assessed for sarcopenia based on the revised European consensus definition. Patients with neuromuscular diseases were diagnosed according to the revised El Escorial criteria and the European neuromuscular centre criteria. Phenotypes and diagnostic criteria for all patients were summarized including their specific histopathological findings.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All patients with neuromuscular diseases were positively screened for sarcopenia and classified as severe sarcopenic by means of assessment. The clinical phenotype, the evolution pattern of weakness and muscle atrophy combined with laboratory finding including electromyography could unquestionably distinguish the diseases.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Neuromuscular disorders can manifest beyond the age of 65&#xa0;years and misdiagnosed as sarcopenia. The most common diseases are inclusion body myositis, amyotrophic lateral sclerosis and myotonic dystrophy type 2. A diagnostic work-up for neuromuscular diseases ensures their correct diagnosis by clinical-, electrophysiological, histopathological, and genetic work-up.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In geriatric patients with a focal or asymmetrical muscular weakness and atrophy, sarcopenia assessment should be extended with patient's history of disease course. Furthermore, concomitant diseases, analysis of serum creatine kinase, electrophysiological examination, and in selected patients muscle biopsy and gene analysis is needed to rule out a late-onset neuromuscular disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hofmeister</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, Geriatrics, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baber</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, Geriatrics, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Uta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, Geriatrics, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hintze</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarmusch</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, Geriatrics, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krause</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meinke</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehaffey</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General-, Trauma- and Reconstructive Surgery, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuerburg</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General-, Trauma- and Reconstructive Surgery, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangenelli</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, Geriatrics, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoser</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Friedrich-Baur-Institute, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drey</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6709-9672</Identifier><AffiliationInfo><Affiliation>Department of Medicine IV, Geriatrics, University Hospital, LMU Munich, Munich, Germany. Michael.Drey@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>721577</GrantID><Agency>H2020 Marie Sk&#x142;odowska-Curie Actions</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009223" MajorTopicYN="N">Myotonic Dystrophy</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="N">Neuromuscular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055948" MajorTopicYN="N">Sarcopenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Inclusion body myositis</Keyword><Keyword MajorTopicYN="N">Myotonic dystrophy type 2</Keyword><Keyword MajorTopicYN="N">Neuromuscular disease</Keyword><Keyword MajorTopicYN="N">Sarcopenia</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>26</Day><Hour>5</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34172001</ArticleId><ArticleId IdType="pmc">PMC8229316</ArticleId><ArticleId IdType="doi">10.1186/s12883-021-02264-y</ArticleId><ArticleId IdType="pii">10.1186/s12883-021-02264-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cruz-Jentoft AJ, Bahat G, Bauer J, Oirie YVESB, Ruy&#xe8;re OLB, In SA, et al. Sarcopenia&#x202f;: revised European consensus on definition and diagnosis. Age Ageing. 2019;48 September 2018:16&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322506</ArticleId><ArticleId IdType="pubmed">30312372</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips A, Strobl R, Vogt S, et al. Sarcopenia is associated with disability status&#x2014;results from the KORA-Age study. Osteoporos Int. 2017;28:2069&#x2013;2079. doi: 10.1007/s00198-017-4027-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-017-4027-y</ArticleId><ArticleId IdType="pubmed">28386704</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudart C, Rizzoli R, Bruy&#xe8;re O, Reginster J-Y, Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72:45. doi: 10.1186/2049-3258-72-45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2049-3258-72-45</ArticleId><ArticleId IdType="pmc">PMC4373245</ArticleId><ArticleId IdType="pubmed">25810912</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimachkie MM, M.D. and Richard J. Barohn MD. Inclusion Body Myositis Semin Neurol. 2012;32:237&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3535450</ArticleId><ArticleId IdType="pubmed">23117948</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos MO, Gromicho M, Pinto S, De M. Very late-onset amyotrophic lateral sclerosis in a Portuguese cohort. Amyotroph Lateral Scler Front Degener. 2018;19(7&#x2013;8):619&#x2013;622. doi: 10.1080/21678421.2018.1510010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1510010</ArticleId><ArticleId IdType="pubmed">30265147</ArticleId></ArticleIdList></Reference><Reference><Citation>Udd B, Meola G, Krahe R, Thornton C, Ranum LPW, Bassez G, et al. 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord. 2006;16:403&#x2013;413. doi: 10.1016/j.nmd.2006.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2006.03.010</ArticleId><ArticleId IdType="pubmed">16684600</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash MMT. El Escorial rivisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyothrop Lateral Scler Other Mot Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose MR. 188th ENMC International Workshop: Inclusion Body Myositis, 2&#x2013;4 December 2011, Naarden. The Netherlands Neuromuscul Disord. 2013;23:1044&#x2013;1055. doi: 10.1016/j.nmd.2013.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2013.08.007</ArticleId><ArticleId IdType="pubmed">24268584</ArticleId></ArticleIdList></Reference><Reference><Citation>Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, et al. Myotonic dystrophy type 2 ( DM2) and related disorders Report of the 180th ENMC Workshop including guidelines on diagnostics and management 3&#x2013;5 December 2010, Naarden. The Netherlands Neuromuscul Disord. 2011;21:443&#x2013;450. doi: 10.1016/j.nmd.2011.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2011.03.013</ArticleId><ArticleId IdType="pubmed">21543227</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanganelli F, Meinke P, Hofmeister F, Jarmusch S, Baber L. Type-2 Muscle Fiber Atrophy is Associated with Sarcopenia in Elderly Men with Hip Fracture. Exp Gerontol. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33248151</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai H, Cui L, Guan Y, Liu M, Li X, Shen D, et al. Correlation of Creatine Kinase Levels with Clinical Features and Survival in Amyotrophic Lateral Sclerosis. Front Neurol. 2017;8 JUL:1&#x2013;5. doi:10.3389/fneur.2017.00322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494475</ArticleId><ArticleId IdType="pubmed">28717355</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Al-chalabi A, Baker MR, Cui L, De CM, Eisen A, et al. A Proposal for New Diagnostic Criteria for ALS. Clin Neurophysiol. 2020;131:1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce NC, Jin L. Muscle Biopsy Evaluation in Neuromuscular Disorders. Phys Med Rehabil Clin N Am. 2012;23:609&#x2013;631. doi: 10.1016/j.pmr.2012.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2012.06.006</ArticleId><ArticleId IdType="pmc">PMC4590778</ArticleId><ArticleId IdType="pubmed">22938878</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, Mori-yoshimura M, Yamashita S, Nakano S, Murata K, Mori M, et al. The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan. Orphanet J Rare Dis. 2019;14:1&#x2013;9. doi: 10.1186/s13023-019-1122-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-019-1122-5</ArticleId><ArticleId IdType="pmc">PMC6595668</ArticleId><ArticleId IdType="pubmed">31242950</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter JE, Macinnis RJ, Wattanapenpaiboon N, Nowson CA. BMI and all-cause mortality in older adults : a meta-analysis. Am J Clin Nutr. 2014;99:875&#x2013;890. doi: 10.3945/ajcn.113.068122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.113.068122</ArticleId><ArticleId IdType="pubmed">24452240</ArticleId></ArticleIdList></Reference><Reference><Citation>Peric S, Bozovic I, Nisic T, Banovic M, Vujnic M, Svabic T, et al. Body composition analysis in patients with myotonic dystrophy types 1 and 2. Neurol Sci. 2019;40:1035&#x2013;1040. doi: 10.1007/s10072-019-03763-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03763-0</ArticleId><ArticleId IdType="pubmed">30790082</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagnese F, Mondello S, Wenninger S, Kress W, Schoser B. Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2. J Neurol. 2017;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">29086017</ArticleId></ArticleIdList></Reference><Reference><Citation>Sergi G, Rui M De, Veronese N, Bolzetta F, Berton L, Carraro S, et al. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr. 2014;:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25103151</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14:531&#x2013;532. doi: 10.1016/j.jamda.2013.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2013.05.018</ArticleId><ArticleId IdType="pubmed">23810110</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf C. The Lawton instrumental Activities of Daily Living (IADL) Scale. Am J Nurs. 2008;108:52&#x2013;62. doi: 10.1097/01.NAJ.0000314810.46029.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.NAJ.0000314810.46029.74</ArticleId><ArticleId IdType="pubmed">18367931</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B. Screening for Undernutrition in Geriatric Practice: Developing the Short-Form Mini-Nutritional Assessment (MNA-SF) Journals Gerontol Ser A Biol Sci Med Sci. 2001;56:M366&#x2013;M372. doi: 10.1093/gerona/56.6.M366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/56.6.M366</ArticleId><ArticleId IdType="pubmed">11382797</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A, Mohr M, Lannes B, Tranchant C. Myopathies in the elderly: A hospital-based study. Neuromuscul Disord. 2010;20:443&#x2013;447. doi: 10.1016/j.nmd.2010.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2010.05.003</ArticleId><ArticleId IdType="pubmed">20621722</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berg-Vos RM, Visser J, Kalmijn S, Fischer K, de Visser M, de Jong V, et al. A Long-term Prospective Study of the Natural Course of Sporadic Adult-Onset Lower Motor Neuron Syndromes. Arch Neurol. 2009;66. doi:10.1001/archneurol.2009.91.</Citation><ArticleIdList><ArticleId IdType="pubmed">19506135</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt K, Schmidt J. Inclusion body myositis: Advancements in diagnosis, pathomechanisms, and treatment. Curr Opin Rheumatol. 2017;29:632&#x2013;638. doi: 10.1097/BOR.0000000000000436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000436</ArticleId><ArticleId IdType="pubmed">28832349</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology&#x2014;update 2014. J Cachexia Sarcopenia Muscle. 2014;5:253&#x2013;259. doi: 10.1007/s13539-014-0161-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13539-014-0161-y</ArticleId><ArticleId IdType="pmc">PMC4248415</ArticleId><ArticleId IdType="pubmed">25425503</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir&#xf3; &#xd2;, Perea M, Pic&#xf3;n M. Muscle Diseases in Elders : A 10-Year Retrospective Study. J Gerontol Med Sci. 2002;57:378&#x2013;384. doi: 10.1093/gerona/57.6.M378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/57.6.M378</ArticleId><ArticleId IdType="pubmed">12023267</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE, et al. Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly. Obes Res. 2004;12:1996&#x2013;2004. doi: 10.1038/oby.2004.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2004.250</ArticleId><ArticleId IdType="pubmed">15687401</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>